Education
About Us
Working with TipRanks
Follow Us
USANA Health (USNA)
NYSE:USNA
USNA Stock Chart & Stats
$22.53
-$0.56(-1.60%)
At close: 4:00 PM EST
$22.53
-$0.56(-1.60%)
Day’s Range― - ―
52-Week Range$16.72 - $38.32
Previous CloseN/A
Volume19.92K
Average Volume (3M)173.43K
Market Cap
$320.78M
Enterprise Value$176.40M
Total Cash (Recent Filing)$158.38M
Total Debt (Recent Filing)$14.00M
Price to Earnings (P/E)33.6
Beta1.06
Next Earnings
Apr 28, 2026EPS Estimate
0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.60
Shares Outstanding18,456,936
10 Day Avg. Volume170,208
30 Day Avg. Volume173,431
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market Cap0.55
Enterprise Value/Revenue0.19
Enterprise Value/Gross Profit0.24
Enterprise Value/Ebitda1.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.84
Revenue Forecast (FY)$942.40M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthUSANA’s very low leverage and large equity base provide durable financial flexibility. With debt-to-equity near 2.6%, the company can fund retail rollouts, working-capital needs, or technology investments without stressing solvency, cushioning execution risk during a multi-quarter turnaround.
Retail And Distribution ExpansionMajor retail placements (Target, Costco, Canada/U.K.) materially diversify USANA’s go-to-market beyond direct selling. Durable omnichannel distribution can scale branded venture revenue, improve brand awareness, and provide repeatable retail demand that supports multi-quarter revenue growth and reduces single-channel concentration risk.
Experienced Leadership And Strategic RefocusThe return of a prior CEO with a record of expansion brings operational continuity and execution credibility. A clear strategic agenda—omnichannel push, product pipeline, tech modernization—plus announced cost realignment demonstrates focused management alignment to restore growth and margins over the medium term.
Bears Say
Weak Cash GenerationMaterial FCF erosion and weaker cash conversion reduce financial optionality. With FCF covering only ~38% of net income and a 54% YoY decline, the company has less internal capital to fund inventory builds, retail execution, tech investments, or shareholder returns without increasing external financing or diluting flexibility.
Elevated Inventory And Working-capital RiskA 48% inventory build to support retail launches ties up capital and raises obsolescence and execution risk. Sustained elevated stock levels can depress cash conversion and returns if retail sell-through lags, increasing financing needs and pressuring margins during the multi-quarter expansion phase.
Very High Effective Tax-rate GuidanceA 55–60% effective tax rate materially compresses net income even if sales rise. This fiscal-year structural tax burden reduces cash available for reinvestment, cuts through return-on-equity, and limits the earnings leverage from the company’s retail and venture-brand growth initiatives across the next several quarters.
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $16.71 and its highest was $38.32 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $320.78M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Apr 28, 2026 which is in 35 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Feb 17, 2026. The company reported $0.6 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.19.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.44.
How many shares outstanding does USANA Health have?
USANA Health has 18,456,936 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of $0.6 in its last earnings report, beating expectations of $0.41. Following the earnings report the stock price went down -8.035%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
USNA Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 69.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $201.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
2.03%
Trailing 12-Months
Asset Growth
-0.71%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive outlook: clear positives include retail wins for Hiya and Rise Wellness, a 4% midpoint sales growth outlook for FY2026, experienced leadership returning to CEO, and cost savings from workforce realignment. Offsetting these positives are meaningful risks — notably a 48% inventory build, a very high effective tax rate guidance of 55–60%, core-business sales declines, and FY2026 margin pressure from venture-brand mix with Rise only expected to breakeven. Management conveyed confidence and a concrete strategic plan, but several financial and execution risks remain that balance the positive operational developments.View all USNA earnings summariesTechnical Analysis
Ownership Overview
41.38% Insiders
11.16% Mutual Funds
13.26% Other Institutional Investors
21.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---